Topical pain relievers are medications directly applied to the epidermal layer of skin at the area of pain or inflammation.
Topical pain relievers are designed to relieve pain and use skin as the vehicle for drug administration and exert predominant action at targeted site and in the central nervous system.
These medications are available in the form of creams, foams, gels, roll-ons, sprays, sticks, and patches.Read Report Overview – https://www.transparencymarketresearch.com/topical-pain-relief-market.htmlAccording to Global Burden of Disease 2013 (GBD 2013), around 242 million people in the world were living with symptomatic and activity limiting osteoarthritis.
Other key drivers fueling the global topical pain relief market are rise in awareness among patients about the adverse effects of particular drugs and associated pathways, increase in the number of patients undergoing prolonged treatment for diseases such as skin cancer, surge in demand for pain relievers among sportspersons, and increase in the global geriatric population.However, potential restraints of the global pain relief market are burning sensation, skin irritation, and allergic reactions due to usage of pain relievers.
In terms of distribution channel, the market can be categorized into hospitals, pharmacies, retail stores, and online pharmacies.In terms of region, the global topical pain relief market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Each region can be divided into specific countries/sub-regions such as the U.S., Canada, Germany, the U.K., Brazil, India, Japan, and GCC Countries.